Rebecca Shatsky

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 672 citations · Full text

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 300 citations · Full text

I-spy2 Trial, Breast Oncology, Medicine +7

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim et al. · Nature Communications · 2020 · 276 citations · Full text

Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department

Christopher J. Coyne, Vivian Le, Jesse J. Brennan et al. · Annals of Emergency Medicine · 2016 · 70 citations · Full text

Disease Risk Assessment, Adverse Event, Acute Care +11

Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies

Rebecca Shatsky, Barbara A. Parker, Nam Q. Bui et al. · Molecular Cancer Therapeutics · 2019 · 41 citations